Lenus, The Irish Health Repository  > Hospital Research  > Leinster  > St. James's Hospital  >

Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.

Hdl Handle:
http://hdl.handle.net/10147/621143
Title:
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.
Authors:
Kieran, Jennifer Ann; Norris, Suzanne; O'Leary, Aisling; Walsh, Cathal; Merriman, Raphael; Houlihan, D; McCormick, P Aiden; McKiernan, Susan; Bergin, Colm; Barry, Michael
Citation:
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study. 2015, 15:471 BMC Infect. Dis.
Publisher:
BioMed Central
Journal:
BMC infectious diseases
Issue Date:
26-Oct-2015
URI:
http://hdl.handle.net/10147/621143
DOI:
10.1186/s12879-015-1208-1
PubMed ID:
26503519
Abstract:
Recent advances in Hepatitis C therapeutics offer the possibility of cure but will be expensive. The cost of treatment may be partially offset by the avoidance of advanced liver disease. We performed a micro-costing study of the ambulatory healthcare utilisation of patients with Hepatitis C supplemented with inpatient diagnosis related group costs.
Item Type:
Article
Language:
en
Keywords:
HEPATITIS C; HEALTH ECONOMICS
MeSH:
Adult; Ambulatory Care; Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Costs and Cost Analysis; Cross-Sectional Studies; Female; Hepatitis C; Hepatitis C, Chronic; Humans; Ireland; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged
ISSN:
1471-2334

Full metadata record

DC FieldValue Language
dc.contributor.authorKieran, Jennifer Annen
dc.contributor.authorNorris, Suzanneen
dc.contributor.authorO'Leary, Aislingen
dc.contributor.authorWalsh, Cathalen
dc.contributor.authorMerriman, Raphaelen
dc.contributor.authorHoulihan, Den
dc.contributor.authorMcCormick, P Aidenen
dc.contributor.authorMcKiernan, Susanen
dc.contributor.authorBergin, Colmen
dc.contributor.authorBarry, Michaelen
dc.date.accessioned2017-03-07T10:06:49Z-
dc.date.available2017-03-07T10:06:49Z-
dc.date.issued2015-10-26-
dc.identifier.citationHepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study. 2015, 15:471 BMC Infect. Dis.en
dc.identifier.issn1471-2334-
dc.identifier.pmid26503519-
dc.identifier.doi10.1186/s12879-015-1208-1-
dc.identifier.urihttp://hdl.handle.net/10147/621143-
dc.description.abstractRecent advances in Hepatitis C therapeutics offer the possibility of cure but will be expensive. The cost of treatment may be partially offset by the avoidance of advanced liver disease. We performed a micro-costing study of the ambulatory healthcare utilisation of patients with Hepatitis C supplemented with inpatient diagnosis related group costs.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsArchived with thanks to BMC infectious diseasesen
dc.subjectHEPATITIS Cen
dc.subjectHEALTH ECONOMICSen
dc.subject.meshAdult-
dc.subject.meshAmbulatory Care-
dc.subject.meshAntiviral Agents-
dc.subject.meshCarcinoma, Hepatocellular-
dc.subject.meshCost-Benefit Analysis-
dc.subject.meshCosts and Cost Analysis-
dc.subject.meshCross-Sectional Studies-
dc.subject.meshFemale-
dc.subject.meshHepatitis C-
dc.subject.meshHepatitis C, Chronic-
dc.subject.meshHumans-
dc.subject.meshIreland-
dc.subject.meshLiver Cirrhosis-
dc.subject.meshLiver Neoplasms-
dc.subject.meshLiver Transplantation-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.titleHepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.en
dc.typeArticleen
dc.identifier.journalBMC infectious diseasesen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.